EYED-002 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

13,697 results for “EYED-002”

Trials

View all 7275 →

Biochemical Factors for a Dry Eyed Population

40 participants · First posted Aug 30, 2007

DEMETRA - ADVICE-002-2022

246 participants · First posted May 27, 2022

Single and Multiple Ascending Dose Study of KN-002

117 participants · First posted Aug 16, 2021

Drugs

View all 5187 →

Timolol Sustained Release Intraocular Implant (EyeD Pharma)

Black-eyed pea

EYD-002

Organizations

View all 88 →

Eyed Pharma

Belgium

BAYLOR SCOTT & WHITE RESEARCH INSTITUTE

United States

Odyssey Therapeutics

News

View all 1147 →

EyeDura Partners with Singapore Eye Research Institute for Insulin-Based Neurotrophic Keratitis Treatment

Pierre Fabre's PFL-002/VERT-002 Enters Phase I/II Trial for NSCLC with MET Alterations

Pierre Fabre's PFL-002/VERT-002 Enters Phase I/II Trial for NSCLC with MET Alterations

Page 1 of 1370